SHANGHAI FOSUN PHARMACEUTICAL GROUPSHANGHAI FOSUN PHARMACEUTICAL GROUPSHANGHAI FOSUN PHARMACEUTICAL GROUP

SHANGHAI FOSUN PHARMACEUTICAL GROUP

No trades
See on Supercharts

2196 fundamentals

SHANGHAI FOSUN PHARMACEUTICAL GROUP financial statements, including revenue, expenses, profit, and loss

The total revenue of 2196 for the last semiannual is 22.09 B HKD, and it's 2.57% higher compared to the previous semiannual. The net income of H1 24 is 1.33 B HKD.

‪0.00‬
Total revenue
Gross profit
Operating income
Pretax income
Net income
Currency: HKD
TTM
Total revenueYoY growth
Gross profitYoY growth
Pretax incomeYoY growth
Net incomeYoY growth
EBITDAYoY growth
EBITYoY growth